Modified quadruple therapy versus bismuth-containing quadruple therapy in first-line treatment of Helicobacter pylori infection in Korea; rationale and design of an open-label, multicenter, randomized controlled trial

BACKGROUND: Clarithromycin-containing triple regimen for eradication of Helicobacter pylori is no longer acceptable in Korea due to high clarithromycin resistance. Concomitant therapy or bismuth-containing quadruple therapy is recommended as an alternative regimen. A recent study in Korea has shown...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Lim, Hyun, Bang, Chang Seok, Shin, Woon Geon, Choi, Jae Ho, Soh, Jae Seung, Kang, Ho Suk, Yang, Young Joo, Hong, Ji Taek, Shin, Suk Pyo, Suk, Ki Tae, Lee, Jae Jun, Baik, Gwang Ho, Kim, Dong Joon
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2018
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6257664/
https://ncbi.nlm.nih.gov/pubmed/30431605
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000013245
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak